FIRST BUSEY CORP /NV/
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
BUSE$29.11-0.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
FINANCIAL STATEMENTS
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
| Three Months Ended March 31, | ||
|---|---|---|
| (dollars in thousands) | 2026 | 2025 |
| Cash flows provided by (used in) operating activities | ||
| Net income (loss) | $49,981 | $(29,990) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Provision for credit losses | 3,058 | 45,593 |
| Amortization of intangible assets | 4,291 | 3,083 |
| Amortization of mortgage servicing rights | 203 | 168 |
| Depreciation and amortization of premises and equipment | 3,578 | 2,649 |
| Net amortization (accretion) on portfolio loans | (5,626) | (1,164) |
| Net amortization (accretion) of premium (discount) on investment securities | (450) | 1,437 |
| Net amortization (accretion) of premium (discount) on time deposits | 8 | (659) |
| Net amortization (accretion) of premium (discount) on FHLB advances and other borrowings | 462 | 433 |
| Impairment of fixed assets held for sale | 11 | 188 |
| Impairment of mortgage servicing rights | (147) | (2) |
| Unrealized (gains) losses recognized on equity securities, net | 963 | 231 |
| (Gain) loss on sales of debt securities, net | (23) | 15,537 |
| (Gain) loss on sales of loans, net | (315) | (197) |
| (Gain) loss on sales of OREO and other repossessed assets | (15) | (16) |
| (Gain) loss on sales of premises and equipment | (85) | 25 |
| (Gain) loss on life insurance proceeds | — | (211) |
| Increase in cash surrender value of bank owned life insurance | (1,616) | (1,235) |
| Provision for deferred income taxes expense (benefit) | (4,728) | 1,761 |
| Stock-based compensation expense | 4,136 | 3,394 |
| Mortgage loans originated for sale | (18,887) | (13,169) |
| Proceeds from sales of mortgage loans | 19,732 | 9,802 |
| (Increase) decrease in other assets | 8,272 | (7,135) |
| Decrease in other liabilities | (11,268) | (22,141) |
| Net cash provided by operating activities | $51,535 | $8,382 |
(continued)
FINANCIAL STATEMENTS
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Continued)
| Three Months Ended March 31, | ||
|---|---|---|
| (dollars in thousands) | 2026 | 2025 |
| Cash flows provided by (used in) investing activities | ||
| Purchases of interest-bearing time deposits in other banks | $(245) | $(100) |
| Proceeds from maturities of interest-bearing time deposits in other banks | 345 | 710 |
| Purchases of equity securities | — | (742) |
| Proceeds from sales of equity securities | 1 | 5,650 |
| Purchases of debt securities available for sale | (140,488) | (336,428) |
| Proceeds from sales of debt securities available for sale | — | 528,940 |
| Proceeds from paydowns and maturities of debt securities available for sale | 75,213 | 92,454 |
| Proceeds from paydowns and maturities of debt securities held to maturity | 21,401 | 11,754 |
| Purchases of restricted bank stock | (8,757) | (10) |
| Proceeds from the redemption of restricted bank stock | 4,041 | 3 |
| Net (increase) decrease in loans | 104,603 | (93,249) |
| Net cash received in (paid for) acquisitions (see Note 2) | — | 385,804 |
| Cash paid for premiums on bank-owned life insurance | (42) | (46) |
| Proceeds from life insurance | — | 3,306 |
| Purchases of premises and equipment | (2,458) | (1,797) |
| Proceeds from disposition of premises and equipment | 296 | — |
| Net proceeds from OREO and other repossessed assets | 1,303 | 14,576 |
| Net cash provided by investing activities | $55,213 | $610,825 |
| Cash flows provided by (used in) financing activities | ||
| Net decrease in deposits | $(169,906) | $(94,060) |
| Net decrease in federal funds purchased and securities sold under agreements to repurchase | (10,565) | (18,270) |
| Proceeds from short-term borrowings | 5,276,801 | — |
| Repayment of short-term borrowings | (5,106,801) | — |
| Proceeds from other borrowings, net of debt issuance costs | 11,000 | 16,667 |
| Repayment of other borrowings | (45) | (30) |
| Cash dividends paid | (27,200) | (14,224) |
| Purchase of treasury stock | (66,149) | (4,836) |
| Cash paid for withholding taxes on stock-based payments | (6,486) | (910) |
| Issuance of treasury stock for the ESPP | 838 | 619 |
| Common stock issuance costs | — | (920) |
| Net cash used in financing activities | $(98,513) | $(115,964) |
| Net increase in cash and cash equivalents | $8,235 | $503,243 |
| Cash and cash equivalents, beginning of period | 280,227 | 682,410 |
| Cash and cash equivalents, ending of period | $288,462 | $1,185,653 |
| SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||
| Cash payments for: | ||
| Interest | $70,701 | $42,514 |
| Non-cash investing and financing activities: | ||
| OREO and other repossessed assets acquired in settlement of loans | $— | $14,844 |
| Transfer of loans held for sale to portfolio loans | 10 | — |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.